 The purpose of this study is to evaluate the persistence of immune response against the three pertussis antigens anti- pertussis toxoid PT, anti-filamentous hemagglutinin FHA and anti-pertactin PRN in subjects who received a booster dose of either aP or Tdap study vaccines or Boostrix during V113_01 study. 